Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Dose vs 24h Antibiotic Prophylaxis in Reduction Mammaplasty
NCT04079686Completed
- Start
- Aug 2019
- Primary completion
- Oct 2024
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, double-blind trial of cefazolin in surgical site infection (SSI) (2 arms). Primary endpoint: Surgical Site Infection at 30 days. Started Aug 2019; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04079686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04079686.